New Zealand’s sharemarket experienced a 0.65% decline, closing at 13,881.88 points despite a strong performance from Fisher & Paykel Healthcare. F&P Healthcare reached a new all-time high, offering a bright spot in an otherwise downcast trading day. Chorus also saw movement following the release of its annual results, though ultimately contributed to the overall market fall. The S&P/NZX 50 Index briefly surpassed 14,000 points at midday before losing ground in the afternoon session. This mixed performance highlights contrasting fortunes for key companies within the New Zealand market. Investors reacted to the broader market conditions, resulting in a generally negative trend despite individual successes. The day's trading reflects ongoing volatility within the New Zealand stock exchange.